Literature DB >> 921315

Cystinotic rickets treated with vitamin D metabolites.

P Etches, D Pickering, R Smith.   

Abstract

A 22-month-old girl with cystinotic rickets was given 1 microgram 1,25-dihydroxycholecalciferol (1,25-DHCC) daily in addition to standard treatment. Her rickets healed and linear growth rate appeared to increase. It is suggested that the effect of 1,25-DHCC and its metabolically active analogues on cystinotic rickets should be further studied.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 921315      PMCID： PMC1544642          DOI： 10.1136/adc.52.8.661

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.

Authors:  S Balsan; M Garabedian; R Sorgniard; M F Holick; H F Deluca
Journal:  Pediatr Res       Date:  1975-07       Impact factor: 3.756

Review 2.  Hormonal control of skeletal and mineral homeostasis.

Authors:  H Rasmussen; P Bordier; K Kurokawa; N Nagata; E Ogata
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

3.  The story of vitamin D: from vitamin to hormone.

Authors:  J B Mason; R W Hay; J Leresche; S Peel; S Darley
Journal:  Lancet       Date:  1974-03-02       Impact factor: 79.321

4.  Studies of vitamin D deficiency in man.

Authors:  M A Preece; C A Ribot; J Pietrek; H T Korn; D M Davies; J A Ford; M G Dunnigan; J L O'Riordan
Journal:  Q J Med       Date:  1975-10

5.  25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.

Authors:  S Balsan; M Garabedian
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808
  5 in total
  1 in total

1.  Effect of indomethacin on clinical progress and renal function in cystinosis.

Authors:  G B Haycock; J Al-Dahhan; R H Mak; C Chantler
Journal:  Arch Dis Child       Date:  1982-12       Impact factor: 3.791
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.